Aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression: patient level meta-analysis of 7,030 women in four randomised trials

BRADLEY R., BRAYBROOKE J., GRAY R., HILLS R., LIU Z., PAN H., Peto R., DODWELL D., MCGALE P., HOWARD C.

Type

Journal article

Journal

The Lancet Oncology

Publisher

Elsevier

Publication Date

23/12/2021

Permalink